Improvement in Overall Survival of Patients with Advanced Renal Cell Carcinoma: Prognostic Factor Trend Analysis from an International Data Set of Clinical Trials-Reference-Cited by-同舟云学术

Improvement in Overall Survival of Patients with Advanced Renal Cell Carcinoma: Prognostic Factor Trend Analysis from an International Data Set of Clinical Trials

Published:2012-12 Issue:6 Volume:188 Page:2095-2100
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Patil Sujata¹,Manola Judith²,Elson Paul³,Negrier Sylvie⁴,Escudier Bernard⁵,Eisen Tim⁶,Atkins Michael⁷,Bukowski Ronald³,Motzer Robert J.¹

Affiliation:

1. Memorial-Sloan Kettering Cancer Center, New York, New York

2. Dana Farber Cancer Institute, Boston, Massachusetts

3. Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio

4. Centre Léon-Bérard, Lyon, France

5. Institut Gustave Roussy, Paris, France

6. Cambridge Biomedical Research Centre, Cambridge, United Kingdom

7. Georgetown-Lombardi Comprehensive Cancer Center, Washington, D.C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Renal cell carcinoma;Motzer;N Engl J Med,1996

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Escudier B, Ravaud, Oudard S et al: Phase III randomized trial of everolimus (RAD001) vs placebo in metastatic renal cell carcinoma. Presented at European Society for Medical Oncology, Stockholm, Sweden, September 12–15, 2008.

4. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p;Cell & Bioscience;2023-08-18

2. Dealing with malignancy involving the inferior vena cava in the 21st century;The Journal of Cardiovascular Surgery;2022-12

3. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3;Cancer Biomarkers;2022-11-18

4. Phase I/ II study of multipeptide cancer vaccine IMA901 after single‐dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long‐term follow up;International Journal of Urology;2022-10-28

5. miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5;Cancer Cell International;2021-07-21